Document is current
Any future updates will be listed below
-
Authors
Lovre, Dragana https://orcid.org/0000-0002-2607-8768
Qadir, M. M. Fahd https://orcid.org/0000-0002-6764-6151
Bateman, Kristin https://orcid.org/0000-0001-8878-4150
Saltzman, Leia Y https://orcid.org/0000-0002-2027-6982
Sherman, Mya
Mauvais-Jarvis, Franck https://orcid.org/0000-0002-0874-0754
-
Funding
Funding for this research was provided by:
Clinical Science Research and Development (1 IK2 CX 002225)
Biomedical Laboratory Research and Development, VA Office of Research and Development (BX003725)
National Institutes of Health (DK074970)
American Diabetes Association (7-20-COVID-051)
- License Information
-
More Information
Article History
Received: 7 June 2024
Accepted: 16 September 2024
First Online: 30 September 2024
Declarations
:
: The authors declare no competing interests.
: This study was supported by National Institutes of Health awards (DK074970) (FMJ), an American Diabetes Association COVID-19 Research Award (7-20-COVID-051) (FMJ), a US Department of Veterans Affairs Merit Review Award (BX003725) (FMJ), a US Department of Veterans Affairs Career Development Award (CX002225) (DL) and the Tulane Center of Excellence in Sex Based Biology & Medicine.
: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
: Not applicable.
: The sponsor of this study is the Center of Excellence in Sex-Based Biology & Medicine at Tulane University, New Orleans, Louisiana, USA. Ethical approval for the study and the consent was obtained from the Tulane institutional review board (IRB) on May 14, 2021. The study was reviewed by the US Food and Drug Administration and granted Investigational New Drug (IND) #152499. In the conduct of this clinical trial, we affirm that all procedures and methodologies employed were rigorously designed and executed in full compliance with the prevailing ethical standards and regulatory guidelines. This encompasses adherence to the principles delineated in the Declaration of Helsinki. We have obtained all necessary informed consent from participants and have ensured the confidentiality and anonymity of their data.
